Yahoo Web Search

Search results

  1. Screening & Surveillance. Prognosis & Treatment Guidance. Molecular Residual Disease (MRD) Recurrence Monitoring. Therapy Selection. Rigorous science. Revolutionary. solutions. Our teams use their scientific expertise to continuously innovate. Publications and abstracts. World-class service for physicians and patients.

  2. Exact Sciences Corp. is a molecular diagnostics company based in Madison, Wisconsin specializing in the detection of early stage cancers. The company's initial focus was on the early detection and prevention of colorectal cancer; in 2014 it launched Cologuard, the first stool DNA test for colorectal cancer.

  3. Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally.

  4. Feb 21, 2023 · Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company generated revenue of $553.0 million for the fourth quarter of 2022 and $2,084.3 million for the full year of 2022, both ended Dec. 31, 2022.

  5. 6,550. Get the latest Exact Sciences Corp (EXAS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

  6. People also ask

  1. People also search for